BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 15022293)

  • 1. Spectroscopic and perfusion magnetic resonance imaging predictors of progression in pediatric brain tumors.
    Tzika AA; Astrakas LG; Zarifi MK; Zurakowski D; Poussaint TY; Goumnerova L; Tarbell NJ; Black PM
    Cancer; 2004 Mar; 100(6):1246-56. PubMed ID: 15022293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noninvasive magnetic resonance spectroscopic imaging biomarkers to predict the clinical grade of pediatric brain tumors.
    Astrakas LG; Zurakowski D; Tzika AA; Zarifi MK; Anthony DC; De Girolami U; Tarbell NJ; Black PM
    Clin Cancer Res; 2004 Dec; 10(24):8220-8. PubMed ID: 15623597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Application of (1)H MR spectroscopic imaging in radiation oncology: choline as a marker for determining the relative probability of tumor progression after radiation of glial brain tumors].
    Lichy MP; Bachert P; Hamprecht F; Weber MA; Debus J; Schulz-Ertner D; Schlemmer HP; Kauczor HU
    Rofo; 2006 Jun; 178(6):627-33. PubMed ID: 16703499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting survival of children with CNS tumors using proton magnetic resonance spectroscopic imaging biomarkers.
    Marcus KJ; Astrakas LG; Zurakowski D; Zarifi MK; Mintzopoulos D; Poussaint TY; Anthony DC; De Girolami U; Black PM; Tarbell NJ; Tzika AA
    Int J Oncol; 2007 Mar; 30(3):651-7. PubMed ID: 17273766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal multivoxel MR spectroscopy study of pediatric diffuse brainstem gliomas treated with radiotherapy.
    Laprie A; Pirzkall A; Haas-Kogan DA; Cha S; Banerjee A; Le TP; Lu Y; Nelson S; McKnight TR
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):20-31. PubMed ID: 15850898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton magnetic resonance spectroscopic imaging to differentiate between nonneoplastic lesions and brain tumors in children.
    Hourani R; Horská A; Albayram S; Brant LJ; Melhem E; Cohen KJ; Burger PC; Weingart JD; Carson B; Wharam MD; Barker PB
    J Magn Reson Imaging; 2006 Feb; 23(2):99-107. PubMed ID: 16374884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinction between recurrent glioma and radiation injury using magnetic resonance spectroscopy in combination with diffusion-weighted imaging.
    Zeng QS; Li CF; Liu H; Zhen JH; Feng DC
    Int J Radiat Oncol Biol Phys; 2007 May; 68(1):151-8. PubMed ID: 17289287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spectroscopic evidence of cerebral axonopathy in patients with "pure" adrenomyeloneuropathy.
    Dubey P; Fatemi A; Barker PB; Degaonkar M; Troeger M; Zackowski K; Bastian A; Smith SA; Pomper MG; Moser HW; Raymond GV
    Neurology; 2005 Jan; 64(2):304-10. PubMed ID: 15668429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of proton magnetic resonance spectroscopy in the noninvasive grading of solid gliomas: comparison of maximum and mean choline values.
    Senft C; Hattingen E; Pilatus U; Franz K; Schänzer A; Lanfermann H; Seifert V; Gasser T
    Neurosurgery; 2009 Nov; 65(5):908-13; discussion 913. PubMed ID: 19834403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Axonal loss is progressive and partly dissociated from lesion load in early multiple sclerosis.
    Pascual AM; Martínez-Bisbal MC; Boscá I; Valero C; Coret F; Martínez-Granados B; Marti-Bonmati L; Mir A; Celda B; Casanova B
    Neurology; 2007 Jul; 69(1):63-7. PubMed ID: 17606882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiparametric MR assessment of pediatric brain tumors.
    Tzika AA; Astrakas LG; Zarifi MK; Petridou N; Young-Poussaint T; Goumnerova L; Zurakowski D; Anthony DC; Black PM
    Neuroradiology; 2003 Jan; 45(1):1-10. PubMed ID: 12525947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation between intra-axial metastatic tumor progression and radiation injury following fractionated radiation therapy or stereotactic radiosurgery using MR spectroscopy, perfusion MR imaging or volume progression modeling.
    Huang J; Wang AM; Shetty A; Maitz AH; Yan D; Doyle D; Richey K; Park S; Pieper DR; Chen PY; Grills IS
    Magn Reson Imaging; 2011 Sep; 29(7):993-1001. PubMed ID: 21571478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal window of metabolic brain vulnerability to concussion: a pilot 1H-magnetic resonance spectroscopic study in concussed athletes--part III.
    Vagnozzi R; Signoretti S; Tavazzi B; Floris R; Ludovici A; Marziali S; Tarascio G; Amorini AM; Di Pietro V; Delfini R; Lazzarino G
    Neurosurgery; 2008 Jun; 62(6):1286-95; discussion 1295-6. PubMed ID: 18824995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developing a clinical decision model: MR spectroscopy to differentiate between recurrent tumor and radiation change in patients with new contrast-enhancing lesions.
    Smith EA; Carlos RC; Junck LR; Tsien CI; Elias A; Sundgren PC
    AJR Am J Roentgenol; 2009 Feb; 192(2):W45-52. PubMed ID: 19155380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton magnetic resonance spectroscopy of brain tumors correlated with pathology.
    Magalhaes A; Godfrey W; Shen Y; Hu J; Smith W
    Acad Radiol; 2005 Jan; 12(1):51-7. PubMed ID: 15691725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton magnetic resonance spectroscopic findings of cerebral fat embolism induced by triolein emulsion in cats.
    Baik SK; Kim YW; Kim HJ; Lee JW; Cho BM; Kim DH; Choi SH; Lee SH; Chang KH
    Acta Radiol; 2008 Dec; 49(10):1174-81. PubMed ID: 19031181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved delineation of brain tumors: an automated method for segmentation based on pathologic changes of 1H-MRSI metabolites in gliomas.
    Stadlbauer A; Moser E; Gruber S; Buslei R; Nimsky C; Fahlbusch R; Ganslandt O
    Neuroimage; 2004 Oct; 23(2):454-61. PubMed ID: 15488395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary study of 3T 1H MR spectroscopy in bone and soft tissue tumors.
    Qi ZH; Li CF; Li ZF; Zhang K; Wang Q; Yu DX
    Chin Med J (Engl); 2009 Jan; 122(1):39-43. PubMed ID: 19187615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue characterization of glioma by proton magnetic resonance spectroscopy and perfusion-weighted magnetic resonance imaging: glioma grading and histological correlation.
    Toyooka M; Kimura H; Uematsu H; Kawamura Y; Takeuchi H; Itoh H
    Clin Imaging; 2008; 32(4):251-8. PubMed ID: 18603178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and imaging study of human immunodeficiency virus-1-infected youth receiving highly active antiretroviral therapy: pilot study using magnetic resonance spectroscopy.
    Gabis L; Belman A; Huang W; Milazzo M; Nachman S
    J Child Neurol; 2006 Jun; 21(6):486-90. PubMed ID: 16948932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.